Evofem Biosciences News

8-K: Current report

May 2 17:30 ET

Evofem Biosciences | 8-K: Current report

Mar 28 17:16 ET

Evofem Biosciences | 10-K: Annual report

Mar 27 08:44 ET

Evofem Biosciences | 8-K: Current report

Mar 27 08:39 ET

Evofem Biosciences | 8-K: Current report

Mar 6 17:20 ET

Evofem Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CVI Investments, Inc.(0.9%),Heights Capital Management, Inc.(0.9%)

Feb 14 15:37 ET

Evofem Biosciences | 8-K: Current report

Feb 1 09:06 ET

Evofem Biosciences | 8-K: Current report

Jan 31 16:28 ET

Evofem Biosciences | 8-K/A: Current report (Amendment)

Jan 25 16:27 ET

Evofem Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Zhang Yan

Jan 12 00:00 ET

Evofem Biosciences | 8-K: Current report

Jan 11 00:00 ET

Evofem Biosciences | 8-K: Current report

Dec 27, 2023 00:00 ET

Evofem Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Kamdar Kim P.

Dec 22, 2023 16:05 ET

Evofem Biosciences | 8-K: Current report

Dec 12, 2023 17:17 ET

Evofem Biosciences | 8-K: Current report

Dec 7, 2023 16:05 ET

Evofem Biosciences: Q3 2023 Earnings Report

Nov 14, 2023 07:05 ET

Evofem Biosciences | 8-K: Current report

Nov 14, 2023 07:00 ET

Evofem Biosciences | 8-K: Current report

Oct 24, 2023 07:40 ET

Evofem Biosciences | D: Filing D

Oct 10, 2023 19:57 ET

Evofem Biosciences | 8-K: Current report

Oct 3, 2023 16:07 ET